@misc{indiciae5fa99ce3a8d7,
  title = {Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection},
  author = {Winkler, E. S. and Gilchuk, P. and Yu, J. and Bailey, A. L. and Chen, R. E. and Zost, S. J. and Jang, H. and Huang, Y. and Allen, J. D. and Case, J. B. and Sutton, R. E. and Carnahan, R. H. and Darling, T. L. and Boon, A. C. M. and Mack, M. and Head, R. D. and Ross, T. M. and Crowe, J. E. and Diamond, M.},
  year = {2020},
  doi = {10.1101/2020.12.28.424554},
  url = {https://www.biorxiv.org/content/10.1101/2020.12.28.424554v1},
  note = {Source identifier: 10.1101/2020.12.28.424554}
}